Evidence map›Paper›PMID 34584797›Full record

ReviewCureus2021

The Coexistence of Chronic Obstructive Pulmonary Disease and Heart Failure.

Khizer Khalid, Jaskamal Padda, Anton Komissarov, Lanson B Colaco, Sandeep Padda, Armughan S Khan, Victor Melt Campos, Gutteridge Jean-Charles

Open access · diamondAbstract readReview
In one paragraph

Review in Cureus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Five-Year Survival and Associated Factors in COPD Patients in Colombia: A Retrospective Cohort Study.International journal of chronic obstructive pulmonary disease · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Khizer KhalidInternal Medicine, Jean-Charles (JC) Medical Center, Orlando, USA.
Jaskamal PaddaInternal Medicine, Jean-Charles (JC) Medical Center, Orlando, USA.
Anton KomissarovInternal Medicine, Jean-Charles (JC) Medical Center, Orlando, USA.
Lanson B ColacoInternal Medicine, Jean-Charles (JC) Medical Center, Orlando, USA.
Sandeep PaddaInternal Medicine, Jean-Charles (JC) Medical Center, Orlando, USA.
Armughan S KhanInternal Medicine, Jean-Charles (JC) Medical Center, Orlando, USA.
Victor Melt CamposInternal Medicine, Jean-Charles (JC) Medical Center, Orlando, USA.
Gutteridge Jean-CharlesInternal Medicine, Jean-Charles (JC) Medical Center, Orlando, USA.
Charleston Area Medical Center · USOrlando Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic obstructive pulmonary disease (COPD) is a chronic illness that is widely prevalent within the United States and has been frequently associated with heart failure (HF). COPD is associated with progressive damage and inflammation of the airways leading to airflow obstruction and inadequate gas exchange. HF represents a decline in the normal functioning of the heart resulting in insufficient pumping of blood through the circulatory system. COPD and HF present with similar signs and symptoms with some variation. There are many specific diagnostic tests and treatment modalities which we use to diagnose COPD and HF, but it becomes an issue when you come across a patient who has both conditions simultaneously. For example, attempting to use an X-ray to diagnose HF in a COPD patient is next to impossible because the results are manipulated by the COPD disease process. This is the case with many other diagnostic tests such as an electrocardiogram (ECG), chest radiography (X-ray), B-type natriuretic peptide (BNP), echocardiogram, cardiac magnetic resonance imaging (CMR), pulmonary function test (PFT), arterial blood gas (ABG), and exercise stress testing. When a patient has both COPD and HF, it becomes more difficult to treat. Many treatments for HF have negative impacts on COPD patients and vice-versa, whereas some have also shown positive clinical outcomes in both diseases. It is agreeable that treatment has to be patient-centered and it can vary from case to case depending on the severity of the disease. Ultimately, in this review, we discuss COPD and HF and how they interplay in their diagnostic and treatment modalities to gain a better understanding of how to effectively manage patients who have been diagnosed with both conditions.

Indexed as

bnpcopdechocardiogramheart failurent-pro bnppft

Identifiers

PMID34584797
PMCPMC8457262
OpenAlexW3194137158

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.